Clinical Trial Update: A Study to Evaluate the Efficacy and Tolerance of WR279,396 for Old World Cutaneous Leishmaniasis [Phase 2]

View source ↗

Summary

Phase 2 trial update on WR279,396 for Old World Cutaneous Leishmaniasis has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Old World Cutaneous Leishmaniasis

Drugs mentioned

• WR279,396

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Old World Cutaneous Leishmaniasis | Phase 2 | Status: COMPLETED | Results posted: 2021-01-07